Skip to content

PHARMA . MANAGEMENT

Active Coöperatieve vennootschap (oud statuut)founded 1990active for 36 yearsFéronstrée 14, 4000 LiègeKBO/BCE: BE 0439.966.462 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 36 filings since 1990
peak of €203,282 in 2020
-€1,362 
lowest -€7,747 in 2006
-€1,362 
peak of €195,837 in 2019
€190,957▼ 0.7%
€58,386▲ 2.4%
Board2 names since 2016
1 director
Owners
99.46%
Documentsfilings and deeds
29-07-20262 days before the deadline
2025abbreviated format
Loss of €1,362

Key points

from the 2025 annual accounts

Filings

36 annual accounts 37 filings since 1990
AprilJune31 JulyOctober1990200020102020

Six of the last ten came late. The 2024 accounts came in latest, 139 days after the end of the period.

Subsidiaries

-€137,574

Subsidiary with negative equity. · loss of €1,140 in 2025.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 12,344 companies had the same profile as PHARMA . MANAGEMENT has now. Each dot stands for 31 companies, two years later.

90.1%
were still trading
8.7%
stopped another way
0.7%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a small loss

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 12,344 companies, not a prediction for PHARMA . MANAGEMENT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager,
  • 99.46%equity -€394,711 (2025) · annual accounts 2025 of

Shares in 1 company,

Board & ownership

Recent changes

Registered office moved within Liège The registered office moved from Rue Agimont 22 à 4000 Liège to En Féronstrée 14 à 4000 Liège · acts as permanent representative · Board meeting of 04-04-2023 · Gazette deed
Registered office moved from Saint-Nicolas to Liège The registered office moved from rue Saint Nicolas 411, 4420 Saint-Nicolas to Rue Agimont 22 à 4000 Liège · acts as permanent representative · Board meeting of 01-02-2020 · Gazette deed
Registered office moved from Waterloo to Saint-Nicolas The registered office moved from Drève Richelle 161 Bte 48, 1410 Waterloo to rue Saint-Nicolas 411, 4420 Saint-Nicolas · resigns as director · appointed as director and manager · General meeting of 30-06-2016 · Gazette deed
Registered office moved from Saint Nicolas to Waterloo The registered office moved from rue Saint Nicolas 411, 4420 Saint Nicolas to Drève Richelle 161 bte 48 bâtiment N, 1410 Waterloo · General meeting of 01-09-2015 · Gazette deed
All 49 events

Official details

Source: KBO
Status
Active since 08-01-1990Normal situation
Activity
Buying and selling of own real estateNACE 68110021 activity on the establishment unit
Establishment unit
2.048.302.676since 21-05-1990
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€249,343=
Filing
Filed on 29-07-2026, 2 days before the end of the filing period
Financials

Insights on PHARMA . MANAGEMENT

PHARMA . MANAGEMENT files the abbreviated format. That format states no turnover. The gross margin fell from €8,026 in 2006 to -€1,362 in 2025.

holds 99.46% of the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMA . MANAGEMENT

What is the company number of PHARMA . MANAGEMENT?
The company number of PHARMA . MANAGEMENT is 0439.966.462. The VAT number is the same number with BE in front: BE 0439.966.462.
Where is PHARMA . MANAGEMENT based?
The registered office is at Féronstrée 14, 4000 Liège.Company details
What is the legal form of PHARMA . MANAGEMENT?
Legal form of PHARMA . MANAGEMENT: Coöperatieve vennootschap (oud statuut).
When was PHARMA . MANAGEMENT founded?
PHARMA . MANAGEMENT was founded on 08-01-1990.
Is PHARMA . MANAGEMENT still active?
Yes, PHARMA . MANAGEMENT is an active enterprise in the KBO register.
What is the turnover of PHARMA . MANAGEMENT?
The annual accounts for financial year 2025 state no turnover.Financials
Is PHARMA . MANAGEMENT profitable?
In financial year 2025, PHARMA . MANAGEMENT made a loss of €1,362.
Where can I find the annual accounts of PHARMA . MANAGEMENT?
PHARMA . MANAGEMENT filed 37 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMA . MANAGEMENT due?
PHARMA . MANAGEMENT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.